Perspective Therapeutics (CATX) Revenue (2010 - 2023)

Perspective Therapeutics has disclosed Revenue across 14 years of filings, most recently posting -$4.9 million for Q4 2023.

• In Q4 2023, Revenue changed N/A year-over-year to -$4.9 million; the TTM figure through Dec 2023 stood at $1.4 million (changed N/A YoY), while the FY2023 annual figure was $1.4 million, changed N/A from the prior year.
• Revenue came in at -$4.9 million for Q4 2023 at Perspective Therapeutics, down from $2.2 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $7.1 million in Q3 2022 to a low of -$4.9 million in Q4 2023.
• Average Revenue over 5 years is $2.4 million, with a median of $2.4 million recorded in 2020.
• Year-over-year, Revenue soared 178.16% in 2022 and tumbled 69.36% in 2023.
• Over 5 years, Revenue stood at $2.2 million in 2019, then advanced by 6.94% to $2.4 million in 2020, then increased by 19.37% to $2.8 million in 2021, then soared by 153.27% to $7.1 million in 2022, then tumbled by 168.73% to -$4.9 million in 2023.
• Per Business Quant data, the three most recent Revenue figures were -$4.9 million in Q4 2023, $2.2 million in Q3 2023, and $2.1 million in Q2 2023.